Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
03/24/1993 | EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
03/24/1993 | EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity |
03/24/1993 | EP0532673A1 Immunoassays for anti-hiv-1 antibodies |
03/24/1993 | EP0532587A1 Methods for trans-destabilization of specific proteins in vivo |
03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
03/24/1993 | EP0345315B1 Ps2 protein derivative |
03/24/1993 | EP0312540B1 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins |
03/24/1993 | EP0248040B1 Ricin-antibody conjugates |
03/24/1993 | EP0211894B1 Fsh |
03/24/1993 | EP0180603B1 Rotavirus |
03/24/1993 | EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna |
03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
03/24/1993 | CA2078801A1 Enzymatically inactive phospholipase d of corynebacterium pseudotuberculosis |
03/23/1993 | US5196516 Pseudorabies virus vaccine |
03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
03/23/1993 | US5196337 Human monoclonal antibody, and its production and use |
03/23/1993 | US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen |
03/23/1993 | US5196321 Methods for in vitro cleavage of ubiquitin fusion proteins |
03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
03/23/1993 | US5196317 Overexpression of proteins in recombinant host cells |
03/23/1993 | US5196316 Enzyme and dna coding therefor |
03/23/1993 | US5196309 Blood disorders |
03/23/1993 | US5196308 Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus |
03/23/1993 | CA1314831C Extraction of human interleukin-4 from bacteria |
03/23/1993 | CA1314830C Bar1 secretion signal |
03/23/1993 | CA1314811C Methods for identifying alleles associated with increased risk of diabetes |
03/21/1993 | WO1993005811A1 A hepatitis b vaccine formulation incorporating a bile acid salt |
03/21/1993 | CA2096650A1 Hepatitis b vaccine formulation incorporating a bile acid salt |
03/21/1993 | CA2078358A1 Multivalent hepatitis b virus vaccine |
03/19/1993 | CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides |
03/18/1993 | WO1993005169A1 Hybrid cytokines |
03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
03/18/1993 | WO1993005166A1 Methods for the selection, separation and fusion of cells |
03/18/1993 | WO1993005153A1 Biocidal proteins |
03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
03/18/1993 | WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer |
03/18/1993 | WO1993005146A1 Molecules with antibody combining sites that induce asymmetry |
03/18/1993 | WO1993005145A1 Cell culture process and medium for the growth of adherent animal cells |
03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |
03/18/1993 | WO1993004586A1 Biocidal proteins |
03/18/1993 | WO1992012992A3 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
03/18/1993 | CA2118707A1 Molecules with antibody combining sites that induce asymmetry |
03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
03/18/1993 | CA2117073A1 Mutated growth factor receptor as a drug and its use for the treatment of cancer |
03/18/1993 | CA2117070A1 Methods for the selection, separation and fusion of cells |
03/18/1993 | CA2116541A1 Biocidal proteins |
03/18/1993 | CA2116533A1 Hybrid cytokines |
03/18/1993 | CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis |
03/18/1993 | CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
03/17/1993 | EP0532430A1 Reagent to identify bacteria of the species Staphylococcus aureus |
03/17/1993 | EP0532359A1 Method of distinguishing cells |
03/17/1993 | EP0532167A2 Non-A, Non-B Hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems |
03/17/1993 | EP0532090A2 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
03/17/1993 | EP0532043A2 Factor Xa linker DNA |
03/17/1993 | EP0531728A1 HSV gD2 Baculovirus expression system |
03/17/1993 | EP0531530A1 Process for producing protein |
03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
03/17/1993 | EP0317641B1 Fused protein containing lymphotoxin |
03/17/1993 | EP0238631B1 Immunoassay method and kit |
03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
03/16/1993 | US5194595 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
03/16/1993 | US5194585 Vasoactive peptides |
03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
03/16/1993 | US5194381 Plasmids and DNA coding for proteins |
03/16/1993 | US5194377 Antibiotic agent |
03/16/1993 | CA2064091C Diagnosis for porcine malignant hyperthermia |
03/15/1993 | EP0594576A4 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products. |
03/14/1993 | CA2078087A1 Hsv gd2 baculovirus expression system |
03/11/1993 | DE4129533A1 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs A mutant growth factor receptor as a medicament and its use for treatment of cancer |
03/10/1993 | EP0531204A1 Purified enzymatic preparation from chromobacterium violaceum, process to obtain it and its use in the production of alpha, beta-dehydrotryptophanyl peptides |
03/10/1993 | EP0531187A1 Yeast promotor and its use |
03/10/1993 | EP0531181A1 Highly stable recombinant yeasts for the production of recombinant proteins |
03/10/1993 | EP0531104A2 Process for producing a lipoprotein-containing substance having a reduced lipid content |
03/10/1993 | EP0530992A2 Enzymatic deprotection of peptides |
03/10/1993 | EP0530937A1 Collagen-induced platelet aggregation inhibitor |
03/10/1993 | EP0530765A2 Gene expression regulatory DNA |
03/10/1993 | EP0530447A2 Process for purifying IgG monoclonal antibodies and their use |
03/10/1993 | EP0530365A1 Human protein c expression vector |
03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
03/10/1993 | EP0489149A4 Probes for detecting mutant p53 |
03/10/1993 | EP0341302B1 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
03/10/1993 | EP0315650B1 Purification of recombinant interleukin-1 |
03/10/1993 | EP0233289B1 Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody |
03/10/1993 | CN1069737A Insulin analogs |
03/10/1993 | CA2077277A1 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
03/09/1993 | US5192694 Anticoagulant, purification by adsorption on support, immunoadsorbent |
03/09/1993 | US5192685 Bifidobacterium strains having high iga induction potential |
03/09/1993 | US5192684 Human IgG1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody |
03/09/1993 | US5192668 Synthesis of protease inhibitor |
03/09/1993 | US5192662 Anti-ganglioside GD1 A monoclonal antibody MZ, MZ-producing cells and MZ-containing reagent |
03/09/1993 | CA1314254C Enzymatic membrane method for the synthesis and separation of peptides |